Article
Diagnostic Products Corp. and Chinese Subsidiary Agree to Fines for Violating the FCPA
On May 20, 2005, Diagnostic Products Corp. ("DPC") and a wholly-owned Chinese subsidiary reached an agreement with the U.S. Securities and Exchange Commission (the "SEC") to settle a probe of alleged violations of the Foreign Corrupt Practices Act (the "FCPA"), and agreed to pay disgorgement of $2,038,727 and prejudgment interest in the amount of $749,895.
Powell Goldstein LLP









